“Imagine a world where transplant patients
do not wait for a donor or a world where burn
victims leave the hospital without disfiguring
scars. Imagine implant materials that can
"grow", reshape themselves, or change their
function as the body requires”
-Professor M.V. Sefton
Dr. Nabarun Biswas
Indoor Medical Officer
SU-2, MMCH
Let’s travel with time
 Year: 2090 AD
 Patient’s age: 85 years
 Problem: liver failure, renal failure with valvular
heart disease
 He was sent to central tissue bank, where his
tissue samples were preserved.
 There his liver, kidney and heart valve was
engineered and replaced
 He was cured and got back to normal life
Let’s back to the present
What is Tissue engineering?
It is the application of engineering and life
science towards the development of
biologic substitute to restore, maintain or
improve functions.
History of TE
 1987: Definition
 1997: Dolly (Somatic cell nuclear transfer)
 1998: Geron corp. figures out how to extend telomeres
 2006: invention of iPSC
Basic science behind T.E.
Cell biology & biochemistry
Stem cell
biology
Cell
signaling
biology
Scaffold
design
Bioreactor
design
Engineered tissue
Material science and engineering
In a nutshell
Where this concept came from
 Tissues have ability to repair
themselves
 Some tissues have
extraordinary power to
regenerate & replace old/
diseased tissue
– Bone,
– Skin
– Gut mucosa
– Blood cell
– Endothelium
Opportunities
Tissue engineering provide treatment for a wide range of
diseases:
 Skin  burn , skin defects
 Cardiac muscle  heart failure
 Heart valves  valvular defects
 Cartilage  degenerative & traumatic disease
 Trachea & bronchus  congenital / malignancy
 Bladder  malformation , cystectomy
 Sphincter  incontinence
 Pancreas  DM type-1
 Blood vessel  atheroma, trauma
 Esophagus Stenosis, malignancy
 Small intestine  failure, crohn’s, cancer
Goal of tissue engineering
 Replacement or repair of diseased
or traumatized tissue or whole organ
 Models to test therapeutic efficacy
& toxicity
Sources of cells for Tissue
engineering
1. Somatic cell
2. Stem cell
Somatic cell
 Fully differentiated
 Obtained from normal
tissue
 Cells may be autologous or
allogeneic
 Examples:
– Epidermal cells
– Chondrocyte
– Bladder wall
Stem cells
 Stem cells are
undifferentiated or non
specialized cells that are
able to renew themselves
indefinitely , through cell
division
 Also able to differentiate
into one or more types of
specialized cells in tissue
after appropriate stimuli.
Stem cell related terms
 Totipotent
 Pluripotent
 Multipotent
 Unipotent
 Reprogramming
– Nuclear transfer
– Gen manipulation
– Viral transduction
Classification of Stem cell
 Embryonic stem cell
 Fetal stem cell
 Adult /somatic stem cell
 Induced pluripotent stem cell
Embryonic stem cell
 J. Thompson, 1998
 Source: IVF
 Totipotent & pluripotent
 Availability
 Expansion in vitro
 Risk of malignancy
 Autologous : NO
 Ethical concern: Yes
Fetal stem cell
 Aborted fetus
 Source: BM, blood
 Pluripotent
 Availability
 Expansion in vitro
 Risk of malignancy
 Autologous: No
 Ethical concern: Yes
Somatic stem cells (SSCs)
 SSCs
resident in
different tissue
& organs
 Responsible
for replacing
old/ diseased
cells
Mesenchymal stem cell
 Multipotent
 Differentiate into
mesodermal tissue
 Collected from ileac
crest aspiration,
liposuction & cord blood
 Availability
 Expansion
 Risk of malignancy
 Autologous
 Ethical concern
Induced pluripotent stem cell
Induced pluripotent stem cell
 Discovered in 2006 by Yamanka
 Somatic cell reprogrammed to stem cell by genetic
manipulation
 Embryonic stem cell like
 Using retroviral / lenti viral transfection
 Cells taken from skin biopsy or blood sample
 Autologous
 Pluripotent
 May lead to activation of oncogenic genes to
prevent Adeno / Sandi virus vector used
Material science and engineering
Where these tissues are
cultured?
– In vivo
– In vitro
Cells
Signal
molecules
Scaffold
Tissue
Engineering
Tissue
Regeneration
In vivo
In vitro
02 Mar 2014
Component of Material science
Material science involves 2 components
1. Scaffold :where cells are seeded
2. Bioreactors : which provide appropriate
physical environment
Scaffold
Scaffold
 Scaffold , that gives physical support and shape
to the engineered tissue, mimicking extra
cellular matrix.
 Allows cells to attach, delivers cell signals
necessary to guide cell growth, migration &
differentiation to form a functional tissue
 Rigid/ semi rigid, 3 Dimensional & porous.
Scaffold
 This animation of a
rotating Carbon
nanotube shows its 3D
structure.
 They are biocompatible,
biodegradable and
bioreabsorbable
Types of scaffold (Natural)
Types of scaffold (Artificial)
Approach to cell seeding
Approach to cell seeding into
scaffold
 Static cell seeding
 Dynamic cell seeding
 Magnetic cell seeding
 Pressure & vacuum seeding
 Photopolymerised hydrogels
 Bioreactor perfusion system
Aim: rapid seeding, high
efficiency, effective penetration
Bioreactors
a) Spinner Flask:
b) Rotating Wall
c) Hollow Fiber
d) Perfusion
e) Controlled Mechanics
Bioreactors
Some engineered tissue
Risk of cell based therapy
 Tumour formation
 Genetic abnormalities
 Transmission of infection
 Poor viability & loss of function
 Differentiation into undesired cell type
 Rejection
 Side effect of immunosuppression
Future directions
 Tissue engineering and regenerative strategies
hold our great hope for effectively repairing or
replacing tissue in a wide number of human
diseases.
 Those patients who suffer from some form of
presently incurable disease, injury or birth
defect can get benefit from tissue engineering
Future directions………….cont.
Some of those may be…….
 One million children with juvenile diabetes
 8.2 million people with cancer
 58 million with heart disease
 Four million suffering from Alzheimer's disease
 10 million with osteoporosis
 43 million arthritis sufferers
 250,000 people paralyzed by spinal cord injuries
 500,000 with Parkinson's disease
www.stemcellresearchfoundation.org/WhatsNew/Benefit.htm
Curious mind want to know..
Tissue engineering

Tissue engineering

  • 1.
    “Imagine a worldwhere transplant patients do not wait for a donor or a world where burn victims leave the hospital without disfiguring scars. Imagine implant materials that can "grow", reshape themselves, or change their function as the body requires” -Professor M.V. Sefton
  • 2.
    Dr. Nabarun Biswas IndoorMedical Officer SU-2, MMCH
  • 3.
  • 4.
     Year: 2090AD  Patient’s age: 85 years  Problem: liver failure, renal failure with valvular heart disease  He was sent to central tissue bank, where his tissue samples were preserved.  There his liver, kidney and heart valve was engineered and replaced  He was cured and got back to normal life
  • 5.
    Let’s back tothe present
  • 6.
    What is Tissueengineering? It is the application of engineering and life science towards the development of biologic substitute to restore, maintain or improve functions.
  • 7.
    History of TE 1987: Definition  1997: Dolly (Somatic cell nuclear transfer)  1998: Geron corp. figures out how to extend telomeres  2006: invention of iPSC
  • 8.
    Basic science behindT.E. Cell biology & biochemistry Stem cell biology Cell signaling biology Scaffold design Bioreactor design Engineered tissue Material science and engineering
  • 9.
  • 10.
    Where this conceptcame from  Tissues have ability to repair themselves  Some tissues have extraordinary power to regenerate & replace old/ diseased tissue – Bone, – Skin – Gut mucosa – Blood cell – Endothelium
  • 11.
    Opportunities Tissue engineering providetreatment for a wide range of diseases:  Skin  burn , skin defects  Cardiac muscle  heart failure  Heart valves  valvular defects  Cartilage  degenerative & traumatic disease  Trachea & bronchus  congenital / malignancy  Bladder  malformation , cystectomy  Sphincter  incontinence  Pancreas  DM type-1  Blood vessel  atheroma, trauma  Esophagus Stenosis, malignancy  Small intestine  failure, crohn’s, cancer
  • 12.
    Goal of tissueengineering  Replacement or repair of diseased or traumatized tissue or whole organ  Models to test therapeutic efficacy & toxicity
  • 13.
    Sources of cellsfor Tissue engineering 1. Somatic cell 2. Stem cell
  • 14.
    Somatic cell  Fullydifferentiated  Obtained from normal tissue  Cells may be autologous or allogeneic  Examples: – Epidermal cells – Chondrocyte – Bladder wall
  • 15.
    Stem cells  Stemcells are undifferentiated or non specialized cells that are able to renew themselves indefinitely , through cell division  Also able to differentiate into one or more types of specialized cells in tissue after appropriate stimuli.
  • 16.
    Stem cell relatedterms  Totipotent  Pluripotent  Multipotent  Unipotent  Reprogramming – Nuclear transfer – Gen manipulation – Viral transduction
  • 17.
    Classification of Stemcell  Embryonic stem cell  Fetal stem cell  Adult /somatic stem cell  Induced pluripotent stem cell
  • 18.
    Embryonic stem cell J. Thompson, 1998  Source: IVF  Totipotent & pluripotent  Availability  Expansion in vitro  Risk of malignancy  Autologous : NO  Ethical concern: Yes
  • 19.
    Fetal stem cell Aborted fetus  Source: BM, blood  Pluripotent  Availability  Expansion in vitro  Risk of malignancy  Autologous: No  Ethical concern: Yes
  • 20.
    Somatic stem cells(SSCs)  SSCs resident in different tissue & organs  Responsible for replacing old/ diseased cells
  • 21.
    Mesenchymal stem cell Multipotent  Differentiate into mesodermal tissue  Collected from ileac crest aspiration, liposuction & cord blood  Availability  Expansion  Risk of malignancy  Autologous  Ethical concern
  • 22.
  • 23.
    Induced pluripotent stemcell  Discovered in 2006 by Yamanka  Somatic cell reprogrammed to stem cell by genetic manipulation  Embryonic stem cell like  Using retroviral / lenti viral transfection  Cells taken from skin biopsy or blood sample  Autologous  Pluripotent  May lead to activation of oncogenic genes to prevent Adeno / Sandi virus vector used
  • 24.
    Material science andengineering Where these tissues are cultured? – In vivo – In vitro Cells Signal molecules Scaffold Tissue Engineering Tissue Regeneration In vivo In vitro
  • 25.
  • 26.
    Component of Materialscience Material science involves 2 components 1. Scaffold :where cells are seeded 2. Bioreactors : which provide appropriate physical environment
  • 27.
  • 28.
    Scaffold  Scaffold ,that gives physical support and shape to the engineered tissue, mimicking extra cellular matrix.  Allows cells to attach, delivers cell signals necessary to guide cell growth, migration & differentiation to form a functional tissue  Rigid/ semi rigid, 3 Dimensional & porous.
  • 29.
    Scaffold  This animationof a rotating Carbon nanotube shows its 3D structure.  They are biocompatible, biodegradable and bioreabsorbable
  • 30.
  • 31.
    Types of scaffold(Artificial)
  • 32.
  • 33.
    Approach to cellseeding into scaffold  Static cell seeding  Dynamic cell seeding  Magnetic cell seeding  Pressure & vacuum seeding  Photopolymerised hydrogels  Bioreactor perfusion system Aim: rapid seeding, high efficiency, effective penetration
  • 34.
    Bioreactors a) Spinner Flask: b)Rotating Wall c) Hollow Fiber d) Perfusion e) Controlled Mechanics
  • 35.
  • 37.
  • 38.
    Risk of cellbased therapy  Tumour formation  Genetic abnormalities  Transmission of infection  Poor viability & loss of function  Differentiation into undesired cell type  Rejection  Side effect of immunosuppression
  • 39.
    Future directions  Tissueengineering and regenerative strategies hold our great hope for effectively repairing or replacing tissue in a wide number of human diseases.  Those patients who suffer from some form of presently incurable disease, injury or birth defect can get benefit from tissue engineering
  • 40.
    Future directions………….cont. Some ofthose may be…….  One million children with juvenile diabetes  8.2 million people with cancer  58 million with heart disease  Four million suffering from Alzheimer's disease  10 million with osteoporosis  43 million arthritis sufferers  250,000 people paralyzed by spinal cord injuries  500,000 with Parkinson's disease www.stemcellresearchfoundation.org/WhatsNew/Benefit.htm
  • 41.

Editor's Notes

  • #32 Natural: polysaccharide, collagen, fibrin, gelatin & cellulose Artificial: polylactide & polyglycolide`
  • #34 tic